Hormonal therapy in the perimenopause and postmenopause - Short version of the S3 guideline;Hormontherapie in der peri- und postmenopause kurzversion der S3-leitlinie

Geburtshilfe und Frauenheilkunde

Volumn 70, Issue 9, 2010, Pages

  Albring, C ^a   Baum, E ^a   Beckermann, M J ^a   Beckmann, M W ^a   Blettner, M ^a   Bohm B ^a   Brucker, C ^a   Doren M ^a   Emons, G ^a   Foth, D ^a   Geisthovel F ^a   Gudermann, T ^a   Hadji, P ^a   Kiesel, L ^a   Klemperer, D ^a   Konig K ^a   Lindhoff Last, E ^a   Ludolph, A ^a   Mueck, A O ^a   Nass Griegoleit I ^a   Noss, D ^a   Ortmann, O ^a   Petri, E ^a   Rabe, T ^a   Regitz Zagrosek, V ^a   Schulte, H ^a   Siedentopf, F ^a   Strowitzki, T ^a   Windler, E ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLIMACTERIUM; HORMONAL THERAPY; HOT FLUSH; HUMAN; MENOPAUSAL SYNDROME; POSTMENOPAUSE; QUALITY OF LIFE; REVIEW; SWEAT; VAGINA ATROPHY;

EID: 77957281151     PISSN: 00165751     EISSN: 14388804     Source Type: Journal    
DOI: 10.1055/s-0029-1241006     Document Type: Review

References (14)

1. MacLennan A H., Broadbent J L., Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes (review). Cochrane Database of Systematic Reviews 2004 (4) CD002978
2. Perrotta C, Aznar M, Mejia R, Albert X, Ng C W. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women (Review). Cochrane Database Syst Rev 2008 (2) CD005131
3. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women's Health Initiative randomized controlled trial. JAMA 2004 291 1701-1712
4. Cherry N, Gilmour K, Hannaford P, Heagerty A, Khan M A., Kitchener H, McNamee R, Elstein M, Kay C, Seif M, Buckley H. The ESPRIT team. Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial. Lancet 2002 360 2001-2008
5. Manson J E., Hsia J, Johnson K C., Rossouw J E., Assaf A R., Lasser N L., Trevisan M, Black H R., Heckbert S R., Detrano R, Strickland O L., Wong N D., Crouse J R., Stein E, Cushman M, Women's Health Initiative Investigators. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003 349 523-534
6. Wassertheil-Smoller S, Hendrix S L., Limacher M, Heiss G, Kooperberg C, Baird A, Kotchen T, Curb J D., Black H, Rossouw J E., Aragaki A, Safford M, Stein E, Laowattana S, Mysiw W J., WHI Investigators. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA 2003 289 2673-2684
7. Cushman M, Kuller L H., Prentice R, Rodabough R J., Psaty B M., Stafford R S., Sidney S, Rosendaal F R., Women's Health Initiative Investigators. Estrogen plus progestin and risk of venous thrombosis. JAMA 2004 292 1573-1580
8. Farquhar C M., Marjoribanks J, Lethaby A, Lamberts Q, Suckling J A., and the Cochrane HT Study Group. Long-term hormone therapy for perimenopausal and postmenopausal women (Review). Cochrane Database of Systematic Reviews 2005 (3) CD004143 Long-term hormone therapy for perimenopausal and postmenopausal women (Review). New search for studies completed, conclusions not changed. The Cochrane Library 2008 (4)
9. Hsia J, Langer R D., Manson J E., Kuller L, Johnson K C., Hendrix S L., Pettinger M, Heckbert S R., Greep N, Crawford S, Eaton C B., Kostis J B., Caralis P, Prentice R, Women's Health Initiative Investigators. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch Intern Med 2006 166 357-365 Erratum. Arch Intern Med 2006 166 759
10. Rossouw J E., Anderson G L., Prentice R L., LaCroix A Z., Kooperberg C, Stefanick M L., Jackson R D., Beresford S A., Howard B V., Johnson K C., Kotchen J M., Ockene J, Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002 288 321-333
11. Cirillo D J., Wallace R B., Rodabough R J., Greenland P, LaCroix A Z., Limacher M C., Larson J C. Effect of estrogen therapy on gallbladder disease. JAMA 2005 293 330-339
12. Greiser C M., Greiser E M., Dören M. Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis (Review). Hum Reprod Update 2007 13 453-463 Epub 2007 Jun 15[nl]
13. Holmberg L, Anderson H. HABITS (hormonal replacement therapy after breast cancer is it safe?), a randomised comparison: trial stopped. Lancet 2004 363 453-455
14. Philipps B, Sackett D, Badenoch D, Strauss S, Haynes B, Dawes M. Centre of Evidence, Based Medicine Oxford; 2001. Dt. Autorisierte Übersetzung: Schlömer G. FR Gesundheit, Universität Hamburg.